Dividends Calendar Earnings Calendar
BCRX

BCRX | BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Durham, North Carolina, United States

Trade prices

  • Volume:
  • Market Cap: 2.01B
  • Prev closed: 8.2
  • Open: 8.12
  • High: 8.61
  • Low: 8.08
  • 52 week low: 1.58
  • 52 week high: 8.99
  • Dividends:

Next ER: November 8, 2022 



Top Stories (BCRX)

    About the Company

    BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 28, 2023
    November 2, 2022-0.23 / -0.2975.83M / 74.62MBeat!
    August 4, 2022-0.32 / -0.343665.53M / 63.33MBeat!
    May 5, 2022-0.4 / -0.362549.92M / 51.36M
    February 23, 2022-0.1 / -0.29547.16M / 51.06M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 5, 2022 14.05 12.93
    14.32
    12.88
    6.07M 2.26%
    Aug 4, 2022 13.74 12.71
    14.19
    12.35
    11.71M 23.23%
    Aug 3, 2022 11.15 11.29
    11.75
    11.02
    3.18M 0.27%
    Aug 2, 2022 11.12 10.78
    11.15
    10.70
    1.49M 2.58%
    Aug 1, 2022 10.84 10.91
    11.20
    10.77
    1.84M -1.63%
    Jul 29, 2022 11.02 10.93
    11.07
    10.65
    1.84M 0.18%
    Jul 28, 2022 11.00 11.02
    11.09
    10.64
    1.54M -0.45%
    Jul 27, 2022 11.05 10.82
    11.12
    10.64
    2.25M 2.41%
    Jul 26, 2022 10.79 10.76
    11.06
    10.56
    1.92M -1.01%
    Jul 25, 2022 10.90 11.20
    11.20
    10.82
    1.92M -1.89%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1986
    • Employees:110

    News

    News for (BCRX)

    Key Persons

    • CEO :  Jon P. Stonehouse
    • CFO :  Thomas R. Staab II

    Talk about BioCryst Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 8, 2022 (Same day)

    hain akam newr coty pagp pxd fnma athm.ch dva emr dar prgo 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 71
    HOLD 29
    SELL 0

    Their Official Profiles 

    Wikipedia

    Peers / Similar stocks 

    xlv gild srpt 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.